Please upgrade your browser.
CHICAGO -- Almost all patients with papillary renal carcinoma had stable disease or better response to treatment with a drug that targets multiple growth factors, preliminary data from an ongoing trial showed. Daily and intermittent dosing with foretinib resulted in a total clinical benefit greater than 90%, according to researchers here at the International Kidney Cancer Symposium.
Kidney cancer took Alger's cousin Sheri Stears. Melanoma skin cancer killed her best friend Carrie Forrest.
Elementary-age girls who spend at least 70 minutes per week in phys ed consistently do better on standardized reading and math tests than girls who spend less than 35 minutes.
The surgical and medical treatment of renal cell carcinoma (RCC) has changed dramatically in the last several years and continues to constantly evolve.
There is information and assistance for patients, survivors, and caregivers on this website. Your participate is welcome. There is no charge for membership.
Designed to thwart blood vessel growth in tumors
|NeonCRM by Neon One|